Galderma delivered net sales of 4.765 billion USD in the first nine months of 2026, raising our full-year sales guidance.
Read more: galderma.com/news/galderma-r…
#AdvancingDermatology #Q3results $GALD
Galderma receives approval for Restylane® Shaype™ for the chin and jawline in Mexico, marking the first approval for the jawline worldwide.
Read more: galderma.com/news/mexico-app…
#SkinSciencebyGalderma #AdvancingDermatology
97
We are committed to bridging the menopause-skin knowledge gap.
Many women wish they had known earlier how menopause can affect the skin. Greater awareness can help women navigate this transition with confidence.
#RewriteTheFutureOfYourSkin
Read more: galdermaaesthetics.com/menop…
1
117
Post #WorldMenopauseDay, meet Rosie, 38, who went through medically-induced menopause during cancer treatment.
After her recovery, she saw the impact on her skin and made informed choices to address the symptoms.
Read more: galdermaaesthetics.com/menop…
#RewriteTheFutureOfYourSkin
1
348
We’re excited to share that the Chinese NMPA has approved our next-generation anti-wrinkle treatment, designed with PEARL™ Technology, for the improvement of frown lines in adults.
Learn more: galderma.com/galderma-relfyd…
#AdvancingDermatology
#SkinSciencebyGalderma
#ForInvestors
1
3
194
Join Galderma’s analyst call today at 15:30 CET as we discuss our record-breaking Q3 results.
Access the live call here: investors.galderma.com/event…
A recording will be available after the event.
#AdvancingDermatology #Q3results $GALD
3
434
We’re glad to share that Sculptra® – the first proven regenerative biostimulator – has been approved for use on the body in the United Arab Emirates.
#HCPs can learn more at a symposium at AMWC Dubai tomorrow.
Find out more: bit.ly/4yrOvEF
#AdvancingDermatology
1
1,107
At #AMWCDubai Galderma will showcase data across Sculptra®, Restylane® and our neuromodulator portfolio, reinforcing our Injectable Aesthetics leadership.
galderma.com/news/amwc-dubai…
#AdvancingDermatology #SkinSciencebyGalderma
1
1
457
57% of women feel anxious from menopause-related skin changes, which can have negative effects on wellbeing.
On #WorldMenopauseDay, we’re ensuring that women feel good in their skin through every life stage.
#RewriteTheFutureOfYourSkin
Learn more: galdermaaesthetics.com/menop…
1
413
Galderma shares phase II patient-reported outcomes of its atopic dermatitis treatment being investigated for use in children aged 2 to 11.
Read more galderma.com/news/pedra-2026…
#ForInvestors
@PeDRA Research
Galderma signs agreement to acquire ZO Skin Health, strengthening its physician-dispensed skincare offering
galderma.com/news/galderma-s…
1
5
286
Galderma releases latest menopause patient research findings: over half of women say they first put menopause-related skin changes down to aging.
Less than a third recognized menopause as the cause.
Find out more galderma.com/news/the-menopa…
#AdvancingDermatology
#Menopause
1
3
250
Galderma will present new post-hoc results from a long-term extension study of our #atopicdermatitis treatment at the #FallClinical Dermatology Conference this weekend.
Learn more: galderma.com/news/fall-clini…
@dermsquared
#ForInvestors
1
2
201
Over 50% of women learn about menopause-related skin changes by living through them.
At Galderma, we’re raising awareness about the impact of menopause on the skin so women can feel their best during this life transition.
Learn more here: galderma.com/news/aesthetic-…
1
155
Celebrating 30 years of Restylane®.
From the first HA injectable to market, to three pioneering technologies shaping aesthetic medicine.
Here's to 30 years of innovation. galderma.com/news/30-years-r…
#SkinSciencebyGalderma #AdvancingDermatology
1
1
188
We are unveiling new three-year long-term data in atopic dermatitis at @EADV_ 2026 in Vienna.
Learn more: galderma.com/news/eadv-2026-…
#ForInvestors #SkinScienceByGalderma
#EADVCongress
1
3
309
We are thrilled to be attending the @EADV_ congress in Vienna next week!
Learn more about how we’re helping to shape the future of skin health at #EADVCongress: galderma.com/news/eadv-2026-…
#ForHCPs
#AdvancingDermatology #SkinScienceByGalderma
1
2
271
New clinical data from China show that Restylane® Volyme™ is highly effective in the correction of moderate-to-severe temple hollowing, while also achieving high patient and investigator satisfaction.
Read more: galderma.com/news/galderma-r…
#SkinSciencebyGalderma
201
A new home for our next chapter in the Americas.
Galderma has officially opened its U.S. and Latin America headquarters in Miami — strengthening collaboration and building on our continued investment in U.S. growth.
Read more galderma.com/news/galderma-o…
#AdvancingDermatology
Join Galderma’s analyst call today at 13:00 CEST as we discuss our record-breaking H1 first half 2026 results.
Access the live call here: investors.galderma.com/event…
A recording will be available after the event.
#AdvancingDermatology #H1results $GALD
1
2
337












